To investigate the effect of LCL-161 on calreticulin mutant cells, we also created L929 cell ectopically expressing MPN associated calreticulin (CALR) mutations with and without its obligate cytokine receptor scaffold thrombopoietin receptor (MPL). The gene discussed is CALR; the disease is myeloproliferative neoplasm.